Introduction
The nonapeptide bradykinin (BK) is released from high molecular weight precursors, the kininogens, via the action of proteolytic enzymes known as kallikreins. Generation of BK and or lysyl-BK (kallidin) frequently occurs in response to tissue injury or inflammation, where these peptides can exert a variety of biological effects, including vasodilatation, increased vascular permeability, stimulation of pain and hyperalgesia, and enhanced cell proliferation (Proud and Kaplan, 1988; Bhoola et al., 1992) . According to pharmacological criteria, these effects are mediated by at least two different receptors, B1 and B2 receptors (Regoli and Barabe, 1988; Farmer and Burch, 1992) . Radioligand binding studies proved the existence of B2 receptors in a variety of tissues and cell lines (Bathon and Proud, 1991) . Recently the rat, mouse and human B2 kinin receptors, as well as the human B1 kinin receptor, have been cloned (McEachern et al., 1991; Hess et al., 1992; Menke et al., 1994; Webb et al., 1994) and, based on sequence homology, were grouped into the superfamily of the G protein-coupled receptors (GPCRs). These findings were in agreement with previous reports, that BK, via the B2 receptor, is capable of activating phospholipase A and/or C and of inhibiting adenylate cyclase via signal transduction pathways that utilize guanosine nucleotide regulatory proteins (Liebmann and Reissmann, 1990; Gutowski et al., 1991; Liebmann et al., 1991; McEachern et al., 1991; Tippmer et al., 1994) . However, both the subtype of the G protein(s) involved, as well as the effect of guanine nucleotides on [ 3 H]BK binding sites, are not completely understood. It has been reported that in human fibroblasts (Etscheid and Villereal, 1989) and in bovine aortic endothelial cells (Keravis et al., 1991) addition of guanosine nucleotides may induce a reduction of B2 kinin receptor number. In other studies, a change in affinity of B2 kinin receptors (Burch and Axelrod, 1987; Leeb-Lundberg and Mathis, 1990; Liao and Homcy, 1993) or changes in both affinity and receptor number (Mathis and Leeb-Lundberg, 1991) were reported. By contrast, guanosine nucleotides were reported to inhibit [ 3 H]BK binding to the human B2 kinin receptor expressed in COS-7 cells (Hess et al., 1992) , while no effect of these nucleotides was observed on BK binding to receptors in guinea pig lung (Trifilieff et al., 1994) .
Cultured human foreskin fibroblasts express high numbers of B2 kinin receptor, which, when occupied by agonist, are subject to strict regulatory control via internalization and down-regulation (Roscher et al., 1984) . Although G proteins appear to couple these receptors to the synthesis of eicosanoids, thereby accumulating cAMP and the release of inositol phosphates (Roscher et al., 1983; Burch and Axelrod, 1987; Dengler et al., 1990) , little is known regarding the exact mechanism of the interaction between the B2 kinin receptor and these G proteins. In this study, we compared the effect of guanine nucleotides on B2 kinin receptor agonist and antagonist binding to partica Present address: Abteilung für Klinische Chemie und Klinische Biochemie, Universität München, Nussbaumstr. 20, D-80336 München, Germany ulate fractions of human foreskin fibroblasts at 0°C and at 37°C.
We were able to demonstrate that at 37°C the guanosine nucleotides GTP and GDP, and their hydrolysis-resistant analogs, induce a reduction in affinity without a concomitant loss of receptor number in the presence of agonist, but not antagonist. This affinity reduction was reversible by incubation on ice, indicating that at 0°C the B2 kinin receptor is always in a high-affinity state and therefore presumably coupled to a G protein. ]BK, even in the absence of exogenous guanosine nucleotides, rapidly decreased in some preparations with time at 37°C, but was stable in all preparations at 0°C for at least three hours. Therefore, for experimental convenience, all incubations were prepared on ice and kept on ice for up to two hours until being used for studies at 37°C. [ 3 H]BK binding activity measured after a 90 min incubation on ice was referred to as the maximum binding capacity of the preparation used.
Results
In Figure 1 In the experiment shown in Figure 3 H]BK binding activity, measured after an incubation for 5 min at 37°C, was reduced to about 80% of the value obtained after an incubation for 90 min at 0°C. This difference between binding activity at 0°C and 37°C, however, was very variable from one assay to another. Some preparations showed absolutely no difference whereas others revealed at 37°C only 60% of the binding activity as compared to that obtained at 0°C (not shown). Technical reasons such as the temperature during the preparation, the volume of buffer the cells were suspended in, the time of sonification or centrifugation, the protein amount in the assay, or the influence of reducing agents (addition of dithiothreitol and mercaptoethanol) were excluded as the cause for this interassay variability (not shown). The presence of 100 M Gpp[NH]p at 37°C led to a further reduction of [ 
Reduction of [ 3 H]BK Binding by Various Nucleotides
Increasing concentrations of various nucleotides were tested for their capability to reduce [ (-) or presence (+) of 100 M Gpp[NH]p at 0°C for 90 min or at 37°C for 5 min followed by an incubation at 0°C for the time indicated. In the incubation depicted on the last column reaction vials were again incubated at 37°C for 5 min. Thereafter specific binding was measured as described under Materials and Methods. Values represent the mean of triplicate determinations. Another experiment gave similar results. In order to test whether the reduction of B2 kinin receptor affinity by guanosine nucleotides is due to an increase in the dissociation rate, particulate preparations were incubated with [ 
Discussion
Depending on the tissue source or cell line under study BK is reported to stimulate, or to inhibit, a variety of signal transduction pathways. The role of G proteins, however, in the variety of BK signal cascades is not fully elucidated. Human foreskin fibroblasts expressing high numbers of B2 kinin receptor have already been shown to be an excellent tool to study the regulation and the properties of the human B2 kinin receptor, as well as its signal transduction pathways (Roscher et al., 1983 (Roscher et al., , 1984 Dengler et al., 1990; Faussner et al., 1991) . Therefore, we decided to use this cell system to investigate the regulatory role of guanosine nucleotides in the binding of agonist and antagonist to B2 kinin receptors in particulate fractions of human foreskin fibroblasts.
In the presence of GTP, GDP, and their poorly hydrolyzable analogs there was a reduction in agonist ([ (Trifilieff et al., 1994) , since Mg 2+ was not included in the incubation buffer in these studies. As suggested by Keravis et al. (1991) , the regulation of receptors by G proteins may vary depending on differences in species or tissues. . Indeed, in contrast to our results in fibroblasts, the described effect was almost completely blocked by addition of 5 mM MgCl 2 or 5 mM CaCl 2 . In particulate fractions of fibroblasts we found only a single binding site with a K d of 2.3 nM in the presence of 25 mM Mg 2+ at 0°C. As already described for other B2 kinin receptor assays, Mg 2+ (25 mM) reduced agonist affinity, since we obtained a higher K d of 0.7 nM at 0°C in the absence of Mg 2+ (not shown).
A spontaneous reduction of binding activity was observed for agonist and antagonist upon incubation at 37°C. Scatchard analysis of equilibrium binding curves revealed that the reduction in binding activity is the consequence of a change in the affinity of at least a part of the receptors and is not due to a decrease in receptor number. Thus, one can assume that under certain conditions B2 kinin receptors in particulate fractions can change their affinity even in the absence of exogenous guanosine nucleotides. Addition of GTP derivatives led to a further reduction of agonist binding but not antagonist binding. (Liao and Homcy, 1993) . Our results with foreskin fibroblasts are completely different, since incubation at 0°C actually reversed a prior change in affinity induced at 37°C (Figure 3 ). This different influence of the temperature on B2 kinin receptor affinity reduction by guanosine nucleotides may reflect a species-specific difference or might be due to coupling of the B2 kinin receptor to different G proteins in different cell types.
The binding reduction observed for agonist and antagonist binding after an increase of temperature from 0°C to 37°C seems to be due to the change in the affinity of a part of the receptors, as can be seen from the Scatchard plots. In the presence of GTP [␥S] or Gpp[NH]p at 37°C only a low-affinity site for the agonist with a K d of 14.6 Ϯ 4 nM (mean Ϯ S. E., n = 3) was seen. Dissociation kinetics demonstrate that this reduction of receptor affinity by guanosine nucleotides is due to an increase of the dissociation rate for [ (Figure 6 ), as also suggested by other reports (Leeb-Lundberg and Mathis, 1990) . These results clearly indicate that in human foreskin fibroblasts G proteins influence the affinity but not the number of B2 kinin receptors in particulate fractions. This is in contrast to previous results reported by others (Etscheid and Villereal, 1989 ) who observed a 45% reduction in B2 kinin receptor number in the presence of 100 M GTP [␥S] about 10 M). GMP and adenosine nucleotides (ATP, ADP, AMP) showed no effect (not shown). Similar potencies of these nucleotides have been reported for the reduction of B2 kinin receptors in bovine endothelial cells (Keravis et al., 1991) , for the ␤-adrenergic receptor (Lefkowitz et al., 1976) , and for the ␣-adrenergic receptor (Rouot et al., 1980) . The observation that not only GTP but also GDP exerts a strong effect on agonist binding to B2 kinin receptors has important implications when considering any hypothesis for the interaction of the B2 kinin receptor with G proteins.
Results derived from dissociation studies in the presence and absence of Gpp[NH]p (Leeb-Lundberg and Mathis, 1990) led to the suggestion that the B2 kinin receptor may exist in at least two different states that display different affinities depending on coupling to a G protein. In bovine myometrium, the B2 kinin receptor has been suggested to exhibit a high-affinity binding site when coupled to a G protein, and a low-affinity binding site when uncoupled. Building on this assumption, the similar effects of GTP and GDP in our current study may be explained by the existence of an intermediate ternary complex of agonist, receptor and G protein, that is only stable in the absence of GTP and GDP as suggested by others (De Lean et al., 1980; Haga and Haga, 1987; Keravis et al., 1991) . Since GTP and GDP are almost completely lost during the preparation of the particulate fraction, the receptor should remain coupled to the G protein while exhibiting high affinity for the agonist. Under these circumstances our results would imply that GTP or GDP are able to bind to the G protein in this ternary complex only in the presence of an agonist and thereby promote dissociation of the ternary complex. One would also expect neither binding of GTP/GDP to the ternary complex at 0°C nor dissociation of this complex, since receptor affinity was not influenced at this temperature.
At 0°C the agonist binds to B2 kinin receptors only with high affinity. The same appears to be the case for antagonist binding. This, however, can be only deduced indirectly by the fact that an increase of temperature from 0°C to 37°C leads to lower affinities for antagonist binding (Figure 5 B) without apparent loss in receptor number. Several other experiments using antagonist concentrations close to 3 nM at 37°C gave variable binding reductions, ranging between 0% and 40% as compared to values obtained at 0°C. Experiments were performed with prior incubation of particulate fractions with 0.5 nM unlabeled BK in the absence (mainly high-affinity state) and presence of 100 M Gpp[NH]p for 5 min (to induce the low-affinity state). Subsequent assays for 5 min at 37°C with 8 nM [ 3 H]NPC17731 resulted in almost identical antagonist binding activities in both pretreatment groups (not shown). This may suggest that antagonist binding is capable of reversing the affinity reduction, induced by an agonist in the presence of guanosine nucleotides, or that a B2 kinin receptor after dissociation of the agonist immediately returns to its highaffinity conformation. A third explanation taking into account the different consequences of mutations on agonist and antagonist binding (Nardone and Hogan, 1994) may be that the antagonist is not able to differentiate between the high-and the low-affinity states.
Taken together these results are best explained by a model (Figure 7 ) in which B2 kinin receptors (R) are precoupled to G proteins (G) with an empty guanosine nucleotide binding site in the absence of agonist (B) as well as in the presence of antagonist (N). The preceding release of GDP from this receptor-G protein-complex should be fast, not depending on the presence of an agonist. This proposal is also supported by the results of Mathis and Leeb-Lundberg (1991) showing a sensitivity to Gpp[NH]p of soluble B2 kinin receptors of bovine myometrium even when the receptors have been solubilized in the absence of agonist. We have previously shown that gel filtration of B2 kinin receptors solubilized from human foreskin fibroblasts (Faussner et al., 1991) gave an apparent molecular mass for the B2 kinin receptor that was much higher (approximately 250 kDa) than would be expected by the calculated molecular mass of 41 kDa deduced from cDNA analysis (Hess et al., 1992) or by the molecular mass of about 68 kDa that has been found by immunoprecipitation and affinity cross-linking (Abd Alla et al., 1993) . This fact may well be due to co-solubilization of coupled G protein(s). According to the model in Figure 7 , one could speculate that the major task of an agonist is to open the receptor-coupled G protein for binding of either GTP or GDP. Only binding of GTP would relay a signal; however, due to the prevalence of this guanosine nucleotide in the cell this is almost always the case. Furthermore, opening of the G proteins for guanosine nucleotides by agonists should happen only at 37°C, but not at 0°C, and should be blocked by occupation of the receptor with antagonist. Therefore, one can assume that in the absence of an agonist and in the presence of an antagonist, or at 0°C, a complex is formed consisting of G proteins having no guanosine nucleotide bound and of B2 kinin receptors exhibiting a high-affinity binding for agonist as well as for antagonists. This would explain the co-solubilization of B2 kinin receptors and G proteins. A recent publication describing that antagonists like NPC17731 and Hoe140 may act as inverse agonists in rat myometrial cells supposed that the antagonists bind to and stabilize a G protein uncoupled state of the B2 kinin receptor (Leeb-Lundberg et al., 1994) . It should therefore be a low-affinity binding state, always provided that the antagonist is able to discriminate between high-and low-affinity states. In our opinion, however, these data do not demonstrate experimentally that the antagonists preferentially bind to the G protein uncoupled state. The reported fact that antagonists may act as inverse agonists could also be explained by the assumption of a spontaneous opening of the G protein for GTP in the coupled, unoccupied receptor state, Transfer of the C-terminus of the internalizing B2 kinin receptor to the normally not internalizing B1 kinin receptor resulted in almost completed transfer of the internalization pattern, i. e. the receptor chimera responded to stimulation with a B1 kinin receptor agonist with fast receptor internalization (Faussner et al., 1998) , despite the fact that the two receptors have only an overall homology of 36% and even less when comparing only the intracellular domains. This result could be easily explained assuming that the internalization process does not require a specific interaction of the remaining part of the receptor with its Cterminus but requires only access of the internalization machinery to the C-terminus. In the proposed model of a precoupled receptor this access, however, would sterically be blocked by the G protein, thus allowing receptor internalization only after agonist stimulation and following activation/release of the blocking G protein.
Our model shown in Figure 7 contrasts somewhat to models developed for other G protein-coupled receptors (e. g. the muscarinic receptor, where coupling to G proteins is supposed to be a consequence of agonist binding; De Lean et al., 1980; Haga and Haga, 1987; Freissmuth et al., 1989) . Nonetheless, since the G protein-coupled receptors apparently not even share the same seven-transmembrane domain structure as indicated by the fact that the B2 kinin receptor in particular apparently does not have three but only two internal loops (Quitterer et al., 1999) and that they are composed of internal loops and C-termini of very different amino acid composition and length, their regulation by G proteins may also well be very different. [2,3-prolyl-3,4-3 H]bradykinin (108 Ci/mmol) and [prolyl-3,4-3 H]-NPC17731 (48.5 Ci/mmol) were obtained from Du Pont-New England Nuclear (Boston, MA, USA). All nucleotides were from Boehringer Mannheim (Mannheim, Germany). Unlabeled BK and all other reagents were from Sigma (Deisenhofen, Germany). Hoe140 was a gift from Dr. B. Schoelkens (Hoechst, Frankfurt, Germany).
Materials and Methods

Materials
Cell Culture
Two lines of foreskin fibroblasts (# 7241 and #1634) were purchased from ATCC (Rockville, MD, USA). Cells were used between the 5th and 19th passage. Stock cultures were grown in Eagle's basal medium supplemented with Earle's salts, 10% fetal calf serum, and 2 mM glutamine, as described previously (Faussner et al., 1991) . For all experiments confluent stock cultures were trypsinized and split 1:5 -1:8 on tissue culture dishes (100 or 145 mm diameter). Medium was changed after 4 -7 days and subcultures were used upon reaching confluence usually 7 to 14 days after seeding.
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Preparation of Particulate Fibroblast Fractions
